Extracellular adenosine regulates colitis through effects on lymphoid and nonlymphoid cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 307, Issue 3, 2014, Pages

  Kurtz, Courtney C ^a   Drygiannakis, Ioannis ^c   Naganuma, Makoto ^a   Feldman, Sanford ^b   Bekiaris, Vasileios ^d   Linden, Joel ^e   Ware, Carl F ^d   Ernst, Peter B ^c  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BURNHAM INSTITUTE   (United States)

^e LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Adenosine; Adoptive transfer; Colitis; Regulatory T cells

Indexed keywords

ADENOSINE A2 RECEPTOR; CD45RB ANTIGEN; RAG1 PROTEIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL TYPE; COLITIS; CONTROLLED STUDY; FEMALE; HELICOBACTER HEPATICUS; HELPER CELL; HEMATOLOGY ANALYZER; INFLAMMATION; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; WILD TYPE;

A2A ADENOSINE RECEPTOR; ADENOSINE; ADOPTIVE TRANSFER; COLITIS; REGULATORY T CELLS;

ADENOSINE; ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD45; BIOLOGICAL MARKERS; COLITIS; COLON; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HELICOBACTER HEPATICUS; HOMEODOMAIN PROTEINS; INFLAMMATION MEDIATORS; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, ADENOSINE A2A; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 84905234228     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00404.2013     Document Type: Article

References (36)

1. Alam MS, Kurtz CC, Rowlett RM, Reuter BK, Wiznerowicz E, Das S, Linden J, Crowe SE, Ernst PB. CD73 is expressed by human regulatory T helper cells and suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice. J Infect Dis 199: 494-504, 2009.
2. + helper T cells and regulates Helicobacterinduced gastritis and bacterial persistence. Mucosal Immunol 2: 232-242, 2009.
3. 2A-receptorgene-deficient mice. Biochem J 354: 123-130, 2001.
4. Asseman C, Fowler S, Powrie F. Control of experimental inflammatory bowel disease by regulatory T cells. Am J Respir Crit Care Med 162: S185-S189, 2000.
5. Bopp T, Becker C, Klein M, Klein-Hessling S, Palmetshofer A, Serfling E, Heib V, Becker M, Kubach J, Schmitt S, Stoll S, Schild H, Staege MS, Stassen M, Jonuleit H, Schmitt E. Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression. J Exp Med 204: 1303-1310, 2007.
6. Bopp T, Dehzad N, Reuter S, Klein M, Ullrich N, Stassen M, Schild H, Buhl R, Schmitt E, Taube C. Inhibition of cAMP degradation improves regulatory T cell-mediated suppression. J Immunol 182: 4017-4024, 2009.
7. + Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110: 1225-1232, 2007.
8. Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464: 1371-1375, 2010.
9. Chin AC, Parkos CA. Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking. Ann NY Acad Sci 1072: 276-287, 2006.
10. Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ, Brown SA, Rehg JE, Jones ML, Ni HT, Artis D, Turk MJ, Vignali DA. IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11: 1093-1101, 2010.
11. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204: 1257-1265, 2007.
12. Eltzschig HK, Sitkovsky MV, Robson SC. Purinergic signaling during inflammation. N Engl J Med 367: 2322-2333, 2012.
13. 2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. Blood 105: 4707-4714, 2005.
14. Ernst PB, Thompson LF. Much ado about adenosine. Adenosine synthesis and function in regulatory T cell biology. J Immunol 185: 1993-1998, 2010.
15. 2B receptors to inflammatory parameters of experimental colitis. J Immunol 182: 4957-4964, 2009.
16. Friedman DJ, Kunzli BM, Rahim YI, Sevigny J, Berberat PO, Enjyoji K, Csizmadia E, Friess H, Robson SC. CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci USA 106: 16788-16793, 2009.
17. Hasko G, Cronstein B. Regulation of inflammation by adenosine. Front Immunol 4: 85, 2013.
18. Hasko G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol 25: 33-39, 2004.
19. 2BAR expression in nonimmune cells plays an important role in the development of murine colitis. Dig Liver Dis 44: 819-826, 2012.
20. Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine. J Immunol 177: 6780-6786, 2006.
21. 2B receptors ameliorates murine colitis. Br J Pharmacol 155: 127-137, 2008.
22. 2B adenosine receptor gene deletion attenuates murine colitis. Gastroenterology 135: 861-870, 2008.
23. + T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 196: 505-515, 2002.
24. + T cells. J Immunol 174: 1073-1080, 2005.
25. Linden J. Regulation of leukocyte function by adenosine receptors. Adv Pharmacol 61: 95-114, 2011.
26. 2A receptors in the T cell mediated regulation of colitis. J Immunol 177: 2765-2769, 2006.
27. 2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 129: 26-33, 2005.
28. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920, 2001.
29. Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M, Price VH, Grisham MB. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 296: G135-G146, 2009.
30. + T cells. Nat Immunol 8: 1353-1362, 2007.
31. + innate lymphoid cells in tissue regeneration. Curr Opin Immunol 25: 156-160, 2013.
32. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T. Regulatory T cells: how do they suppress immune responses? Int Immunol 21: 1105-1111, 2009.
33. + T regulatory cell-mediated suppression. Immunity 30: 636-645, 2009.
34. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius RE, Powrie F, Vivier E. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 13: 145-149, 2013.
35. te Velde AA de KF, Sterrenburg E, Pronk I, ten Kate FJ, Hommes DW, van Deventer SJ. Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease. Inflamm Bowel Dis 13: 325-330, 2007.
36. Ward JM, Anver MR, Haines DC, Melhorn JM, Gorelick P, Yan L, Fox JG. Inflammatory large bowel disease in immunodeficient mice naturally infected with Helicobacter hepaticus. Lab Anim Sci 46: 15-20, 1996.